-
Haseeb Ahmad has been named as the new president of ABPI
europeanpharmaceuticalreview
May 09, 2019
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
-
Haseeb Ahmad has been named as the new president of ABPI
europeanpharmaceuticalreview
May 09, 2019
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
-
No-deal Brexit could put UK patients at risk of fake medicines
pharmaceutical-technology
February 13, 2019
The Association of the British Pharmaceutical Industry (ABPI), a trade group representing drugmakers in the UK, has warned that patients in the country could be at risk of counterfeit medicines in the event of a no-deal Brexit....
-
ABPI names Elliot Dunster as new Executive Director of Communications
firstwordpharma
January 13, 2019
Elliot Dunster moves from being Head of External Affairs at the ABPI, to head up the reputation, digital and media functions of the group representing the branded pharmaceutical industry in the UK.
-
Patients may have to build drug stockpiles in ‘no deal’ Brexit
pharmaphorum
December 21, 2018
Representatives of the pharma industry and drug distributors have told an influential committee of MPs that patients should consider stockpiling their own drugs if a “no deal” Brexit scenario looks likely.
-
Pharma calls for more detail on plan for post Brexit meds access
pharmatimes
December 11, 2018
The pharmaceutical industry is calling on the government to urgently provide more detail on how it plans to ensure a continued supply of medicines should the UK leave the EU under a ‘no-deal’ scenario.
-
New UK drug pricing deal promises faster medicines access
pharmaphorum
November 27, 2018
The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the almost 60-year-old Pharmaceutical Price Regulation Scheme (PPRS).
-
Lords ask Minister for clarity on access to medicine after Brexit
pharmatimes
November 26, 2018
The House of Lords EU Home Affairs Sub-Committee has written to Matt Hancock MP, Secretary of State for Health and Social Care (DHSC), asking for clarity on the government’s contingency preparations to ensure the UK has continued
-
BHA, ABPI welcome UK’s EU withdrawal agreement
pharmatimes
November 19, 2018
The Brexit Health Alliance (BHA) has welcomed the agreement on the terms of the UK’s withdrawal from the European Union (EU).
-
Phamaceutical trade lobby responds to Brexit deal
pharmafile
November 16, 2018
The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a 585 page draft withdrawal